158 related articles for article (PubMed ID: 14768782)
21. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
22. [Relation between levels of acute phase proteins and copper and the parameters of systolic and diastolic left ventricular function in patients with chronic heart failure].
Málek F; Spacek R; Polásek R; Karel I
Cas Lek Cesk; 2002 Jul; 141(14):456-9. PubMed ID: 12238254
[TBL] [Abstract][Full Text] [Related]
23. Are hematinic deficiencies the cause of anemia in chronic heart failure?
Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
[TBL] [Abstract][Full Text] [Related]
24. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
[TBL] [Abstract][Full Text] [Related]
25. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.
Anand IS; Kuskowski MA; Rector TS; Florea VG; Glazer RD; Hester A; Chiang YT; Aknay N; Maggioni AP; Opasich C; Latini R; Cohn JN
Circulation; 2005 Aug; 112(8):1121-7. PubMed ID: 16103233
[TBL] [Abstract][Full Text] [Related]
26. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
27. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.
Alla F; Al-Hindi AY; Lee CR; Schwartz TA; Patterson JH; Adams KF
Am Heart J; 2007 Jun; 153(6):1074-80. PubMed ID: 17540212
[TBL] [Abstract][Full Text] [Related]
28. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
[TBL] [Abstract][Full Text] [Related]
30. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
[TBL] [Abstract][Full Text] [Related]
31. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
32. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of surgical heart failure therapy by ventricular restoration and restrictive mitral annuloplasty.
Tulner SA; Steendijk P; Klautz RJ; Tops L; Bax JJ; Versteegh MI; Verwey HF; Schalij MJ; van der Wall EE; Dion RA
J Card Fail; 2007 Apr; 13(3):178-83. PubMed ID: 17448414
[TBL] [Abstract][Full Text] [Related]
34. Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure.
Rodríguez-Reyna TS; Arrieta O; Castillo-Martínez L; Orea-Tejeda A; Guevara P; Rebollar V; Granados J
Clin Invest Med; 2005 Feb; 28(1):23-9. PubMed ID: 15770879
[TBL] [Abstract][Full Text] [Related]
35. Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling.
Klecha A; Kawecka-Jaszcz K; Bacior B; Kubinyi A; Pasowicz M; Klimeczek P; Banyś R
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):85-91. PubMed ID: 17301632
[TBL] [Abstract][Full Text] [Related]
36. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure.
Tabet JY; Meurin P; Beauvais F; Weber H; Renaud N; Thabut G; Cohen-Solal A; Logeart D; Ben Driss A
Circ Heart Fail; 2008 Nov; 1(4):220-6. PubMed ID: 19808295
[TBL] [Abstract][Full Text] [Related]
37. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
38. Mitral effective regurgitant orifice area versus left ventricular ejection fraction as prognostic indicators in patients with dilated cardiomyopathy and heart failure.
Venturi F; Gianfaldoni ML; Melina G; Cecchi A; Petix NR; Monopoli A; Taiti A; Mazzoni V; Fantini F
Ital Heart J; 2004 Oct; 5(10):755-61. PubMed ID: 15626272
[TBL] [Abstract][Full Text] [Related]
39. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
[TBL] [Abstract][Full Text] [Related]
40. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]